Ancera Garners $1,277,500 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    21 Business Park Drive Branford, CT 06405
  • Company Description
    The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University. The technology uses magnetic fields to manipulate biologic cells via a ferromagnetic fluid.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor

Trending on Xconomy